Podstawa prawna: art. 56. 1. 2 of Act on Public Offering.

Sofia, Bulgaria, May 13, 2021 - According to the requirements of art. 100t of LPOS, "Sopharma" AD (SFA: "BSE-Sofia" AD, SPH: Warsaw Stock Exchange) notifies that for April 2021 the Company recorded a decrease in sales of 22% compared to the same month of the previous year, incl. 62% increase in domestic sales and 37% decrease in export sales.

In the first four months of 2021 the revenues from sales of products decrease by 29% compared to the same period of 2020, incl. 22% decrease of sales for the domestic market and 32% decrease in export sales.

Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1

kom espi zdz